Stock Analysis on Net

Celgene Corp. (NASDAQ:CELG)

This company has been moved to the archive! The financial data has not been updated since October 31, 2019.

Income Statement

Celgene Corp., consolidated income statement

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Net product sales 15,265 12,973 11,185 9,161 7,564
Cost of goods sold, excluding amortization of acquired intangible assets (587) (461) (438) (420) (386)
Gross profit 14,678 12,512 10,747 8,741 7,178
Other revenue 16 30 45 95 107
Research and development (5,673) (5,915) (4,470) (3,697) (2,431)
Selling, general and administrative (3,250) (2,941) (2,658) (2,305) (2,028)
Amortization of acquired intangible assets (468) (329) (459) (279) (258)
Acquisition related gains (charges) and restructuring, net (112) 1,350 (38) (300) (49)
Operating income 5,191 4,707 3,167 2,255 2,519
Interest and investment income, net 45 105 30 31 28
Interest expense (741) (522) (500) (311) (176)
Other income (expense), net 337 24 (324) 48 (44)
Other income and expense (359) (393) (794) (231) (192)
Income before income taxes 4,832 4,314 2,373 2,024 2,327
Income tax provision (786) (1,374) (373) (422) (328)
Net income 4,046 2,940 1,999 1,602 2,000

Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31).

Income statement item Description The company
Net product sales Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Celgene Corp. net product sales increased from 2016 to 2017 and from 2017 to 2018.
Operating income The net result for the period of deducting operating expenses from operating revenues. Celgene Corp. operating income increased from 2016 to 2017 and from 2017 to 2018.
Income before income taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Celgene Corp. income before income taxes increased from 2016 to 2017 and from 2017 to 2018.
Net income The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Celgene Corp. net income increased from 2016 to 2017 and from 2017 to 2018.